Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo

British Journal of Dermatology

Volumn 135, Issue 2, 1996, Pages 237-240

  Katayama, I ^a   Miyazaki, Y ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; STEROID; TACALCITOL; CELL ADHESION MOLECULE; COLECALCIFEROL;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DENDRITIC CELL; DRUG RESISTANCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PRURIGO; TOPICAL DRUG ADMINISTRATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; SKIN;

ADMINISTRATION, TOPICAL; ADULT; AGED; CELL ADHESION MOLECULES; CHOLECALCIFEROL; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRURIGO; SKIN;

EID: 0029662352     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01153.x     Document Type: Article

References (15)

1. Burton JL. Rook AJ, Wilkinson DS. Nodular prurigo. In: Textbook of Dermatology (Rook AJ, Wilkinson DS, Ebling FJG, Champion RH and Burton JL,. eds), 4th edn, Vol. 1. Oxford: Blackwell Scientific Publications, 1986: 417-18.
2. Payne CMER. Wilkinson JD, Mckee PH et al. Nodular prurigo - a clinicopathological study of 46 patients. Br J Dermatol 1985; 113: 431-9.
3. Vaatainen N, Hannuksela M. Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol (Stockh) 1979; 59: 544-7.
4. Gerristen MJP, Boezeman JBM, van Vlijmen-Willems IMJJ. van De Kerkhof PCM.The effect of tacalcitiol (1,24(OH)2D3) on cutaneous inflammation. epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57-65.
5. Srviastava MD, Deluca H. Ambrus JL, Inhibition of IL6 and IL8 production in human fibroblast cell lines by 1.25(OH)2 vitamin D3 and two of its analogs with lower calcium activity. Res Commun Chem Pathol Pharmacol 1994; 85: 145-50.
6. Burton JL, Rook A, Wilkinson DS. Prurigo. In: Textbook of Dermatology (Rook A, Wilkinson DS, Ebling FJG, Champion RH, eds) 4th edn. Oxford: Blackwell Scientific Publications, 1986; 416-17.
7. Gronneberg R, Strandberg K, Stalenheim G, Zetterstrom O. Effect in man of anti-allergie drugs on the immediate and late phase cutaneous allergic reactions induced by anti-lgE. Allergy 1981; 36: 201-8.
8. Aas K, Effect of ketotifen and clemastine on passive transfer of reaginic reaction. Allergy 1979; 34: 121-4.
9. Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 1990; 145: 2791-6.
10. Texereau M, Viac J, Vitamin D. immune system and skin. Eur J Dermatol 1992; 2: 258-64.
11. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 1992; 339: 324-8.
12. Berth-Jones J, Smith SG, Graham-Brown RAC. Nodular prurigo responds to cyclosporin. Br J Dermatol 1995; 132: 795-9.
13. Hosoi J. Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159-63.
14. Vaalasti A, Suomalainen H, Rechardt L. Calcitonine gene-related peptide immunoreactivity in prurigo noduluris: a comparative study with neurodermatitis circumscripta. Br J Dematol 1989; 120: 619-25.
15. Bieber T. Fc∈RI on human Langerhans cells: a receptor in search of new functions. Immunol Today 1994; 15: 52-3.